Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
University of North Carolina at Chapel Hill · VA San Diego Healthcare System · +3 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,156
total citations
- FWCI
- 46.36
- Percentile
- 100%
- References
- 25
Citations per year
Authors
17- NMNancie M. ArchinCorresponding
University of North Carolina at Chapel Hill
- ALAbigail Liberty
University of North Carolina at Chapel Hill
- ADAngela D. M. Kashuba
University of North Carolina at Chapel Hill
- SKShailesh K. Choudhary
University of North Carolina at Chapel Hill
- JKJoAnn Kuruc
University of North Carolina at Chapel Hill
Topics & keywords
Topics
Keywords
- Vorinostat
- Histone deacetylase
- Virus latency
- Human immunodeficiency virus (HIV)
- Acetylation
- Antiretroviral therapy
- Histone
- Latency (audio)
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.